BDNF and sensorineural hearing loss disorder: Notably, recombinant human BDNF administration was effective in preventing SGC death following hair cell degeneration in vivo [15,30,31,32], and therefore represents a promising therapeutic strategy for the treatment of sensorineural hearing loss.